Robust revenue growth and the announcement of a fresh acquisition weren't enough to push the company into positive territory ...

The landscape in front of BrightView Holdings (BV 7.03%) wasn't looking particularly smooth or handsome on Hump Day. Shares ...

As bad as things may seem, Novo Nordisk still has a robust diabetes and obesity business that should grow over the years.

Join us as we explore Eaton's potential in the industrial sector and why it received high ratings from our analysts. Is this ...

Palantir shares declined sharply on Wednesday, despite 70% revenue growth to $1.41 billion and two analyst upgrades to Buy.

But this market giant isn't only a designer of AI products. It's also an investor in other key AI players. Nvidia held a $4.3 ...

On Feb. 4, 2026, AMD’s AI-chip stumble rattled the Nasdaq while defensive Dow names steadied a suddenly nervous Wall Street.

AMD beat Q4 expectations but fell sharply after projecting $9.8 billion in Q1 revenue, shifting investor focus from earnings ...

On Feb. 4, 2026, investors weighed booming revenue against weaker profit guidance and rising robotaxi investment at this ...

A sell-off in the AI-related sector hit the stock today, but there's reason to believe the market is overreacting.

Perhaps more concerning since it can be measured in dollar value instead of customer count, was Palantir's deceleration in ...

Today, Feb. 4, 2026, investors are weighing Boston Scientific’s guidance against new deals and its long-term margin path.